NEW YORK, June 30, 2014 /PRNewswire/ --

Today, Analysts Review released its analysts' notes regarding Hospira, Inc. (NYSE: HSP), Prothena Corporation PLC (NASDAQ: PRTA), Quintiles Transnational Holdings Inc (NYSE: Q), Sirona Dental Systems, Inc. (NASDAQ: SIRO) and Covance Inc. (NYSE: CVD). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/4253-100free.

-- Hospira, Inc. Analyst Notes On June 25, 2014, Hospira, Inc. (Hospira) issued a press release applauding the Massachusetts Governor Deval Patrick for signing H. 3734, the law that paves the way for the substitution of interchangeable biologic drugs and gives patients access to cost savings from biosimilar products. Dr. Stan Bukofzer, Corporate Vice President and Chief Medical Officer, Hospira said, "The introduction of biosimilars promises to help put new cost-savings in the hands of patients. Massachusetts is now among a growing number of U.S. states taking early action to establish clear and transparent policies for the substitution of these high-quality and more affordable biologic products." Hospira, a market leader in biosimilars in Europe, expects to submit its first biosimilar to the U.S. Food and Drug Administration (FDA) later in 2014 or in early 2015. The full analyst notes on Hospira are available to download free of charge at:

http://www.analystsreview.com/Jun-30-2014/HSP/report.pdf

-- Prothena Corporation PLC Analyst Notes On June 25, 2014, Prothena Corporation PLC (Prothena) announced the pricing of its underwritten public offering of 4.75 million of its ordinary shares at a price to the public of $22.50 per ordinary share, before underwriting discounts and commissions. According to the Company, it has granted the underwriters a 30-day option to purchase ordinary shares of up to an additional 712,500, and added that entities managed by Woodford Investment Management LLP have agreed to purchase 2,222,222 ordinary shares in this offering at the public offering price, without the underwriting discount. Prothena stated that the net proceeds from the ordinary shares to be sold by the Company are expected to be $102.5 million, after deducting the underwriting discount and estimated offering prices, but excluding any exercise of the underwriters' option to purchase additional ordinary shares. Subject to customary closing conditions, this offering is expected to close on June 30, 2014. The full analyst notes on Prothena are available to download free of charge at:

http://www.analystsreview.com/Jun-30-2014/PRTA/report.pdf

-- Quintiles Transnational Holdings Inc Analyst Notes On June 23, 2014, Quintiles Transnational Holdings Inc (Quintiles) reported that it has been recognized as one of IDG Computerworld's 100 Best Places to Work in IT 2014 for the sixth time over the past seven years. Quintiles stated that the annual list is based on company offerings in benefits, career development, training, and retention. Richard Thomas, Chief Information Officer, Quintiles said, "We are delighted to be named for the sixth time as one of the top IT workplaces. It is testament to the quality of our team and their focus on creating value over the long haul. The human edge in technology is more critical now than ever. Having a great workplace and culture is our foundation, and it allows everyone to flourish professionally, lifting our team performance to ever higher levels in everything we do." The full analyst notes on Quintiles are available to download free of charge at:

http://www.analystsreview.com/Jun-30-2014/Q/report.pdf

-- Sirona Dental Systems, Inc. Analyst Notes On June 23, 2014, Sirona Dental Systems, Inc. (Sirona) reported that its company Sirona Dental Systems South Africa donated dental equipment worth nearly ZAR100,000 to a health care of Lungisisa Ndlela Village (LIV), a non-profit organization providing residential foster cluster care for children in Sub-Saharan Africa. Andy Cyprianos, General Manager of Sirona SA said, "We believe that a person's mouth is a gateway to their overall health. Recent studies have linked poor oral health to diseases such as diabetes and heart problems. In contrast to the physical risks, a person's smile can have very positive emotional effects. Research conducted by Harvard School of Dental Medicine indicates that smiling creates optimism." The Company informed that Sirona SA donated a C8+ dental chair offering technical features such as ergonomic and comfortable patient positioning, high-quality materials, an intuitive user interface, and hygiene functions to LIV's new Health Care Center in Verulam, KwaZulu-Natal. The full analyst notes on Sirona are available to download free of charge at:

http://www.analystsreview.com/Jun-30-2014/SIRO/report.pdf

-- Covance Inc. Analyst Notes On June 25, 2014, Covance Inc. (Covance) reported that it will host its Q2 2014 financial results conference call, which will be broadcast live through its website on Wednesday, July 30, 2014, at 9:00 a.m. ET, following the Company's Q2 2014 earnings release, expected to be issued on Tuesday, July 29, 2014, after the market closes. The full analyst notes on Covance are available to download free of charge at:

http://www.analystsreview.com/Jun-30-2014/CVD/report.pdf

-- About Analysts Review We do things differently. Our goal is to provide the best content to our exclusive membership. We are constantly hiring researchers, writers, editors and analysts to add to our team and become better than yesterday. If being a part of a fast growing community with an edge in today's market sounds interesting to you, then sign-up today and experience the full benefits of membership.

=============== EDITOR'S NOTES: ===============

1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.

2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.

3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.

4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.analystsreview.com.

5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.analystsreview.com.

6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.analystsreview.com for consideration.

COMPLIANCE PROCEDURE Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Analysts Review in this article or report according to the procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE Analysts Review makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED Analysts Review is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Analysts Review whatsoever for any direct, indirect or consequential loss arising from the use of this document. Analysts Review expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Analysts Review does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA(R) and Chartered Financial Analyst(R) are registered trademarks owned by CFA Institute.

AnalystsReview.com

SOURCE Analysts Review